The Europe Transcatheter Aortic Valve Replacement Market should witness market growth of 6.8% CAGR during the forecast period (2022-2028).
Several research groups are participating in a clinical research program that keeps running and enables patients’ access to cutting-edge technologies. Some examples of more recent experimental technology are TAVR valves with a smaller diameter, valves with improved sealing, and valves that may be adjusted for more precise placement.
The market opportunities being established by market participants due to the quick pace of clinical research in TAVR Innovations will benefit many heart patients who will profit from TAVR as a procedure for heart valve dysfunction. AVR is performed through extremely small gaps without jarring the chest bones.
As a result, the heart's aortic valve becomes thicker and calcified, preventing it from opening fully and reducing blood flow from the heart to the body's other organs. Heart failure and sudden heart fatalities may result from this. Patients experiencing symptoms and evidence of aortic stenosis are advised to undergo the implant. Patient's quality of life is enhanced with TAVR even if they would otherwise have few remaining therapy alternatives.
Over 1.8 million people in the European Union (EU) and 3.9 million people in Europe lose their lives to cardiovascular disease every year. Furthermore, 37% of all EU fatalities are attributable to CVD. The mortality rates from ischemic heart disease (IHD) and stroke are greater in Central and Eastern Europe compared to Northern, Southern, and Western Europe. Estimates place the number of people with CVD in Europe at 85 million, with about 49 million in the EU. This provides the participants in the transcatheter aortic valve replacement market in the Europe region with excellent growth potential.
The Germany market dominated the Europe Transcatheter Aortic Valve Replacement Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $519.1 million by 2028. The UK market is anticipated to grow at a CAGR of 5.9% during (2022-2028). Additionally, The France market would exhibit a CAGR of 7.6% during (2022-2028).
Based on Material, the market is segmented into Nitinol, Stainless Steel, Cobalt-Chromium and Others. Based on Implantation Procedure, the market is segmented into Transfemoral, Transapical and Transaortic. Based on Mechanism, the market is segmented into Balloon-expanding Valve and Self-expanding Valve. Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Edwards Lifesciences Corporation, MicroPort Scientific Corporation, LivaNova PLC, TTK Healthcare Limited, Meril Life Science Private Limited, JenaValve Technology, Inc., and Bracco S.p.A.
Several research groups are participating in a clinical research program that keeps running and enables patients’ access to cutting-edge technologies. Some examples of more recent experimental technology are TAVR valves with a smaller diameter, valves with improved sealing, and valves that may be adjusted for more precise placement.
The market opportunities being established by market participants due to the quick pace of clinical research in TAVR Innovations will benefit many heart patients who will profit from TAVR as a procedure for heart valve dysfunction. AVR is performed through extremely small gaps without jarring the chest bones.
As a result, the heart's aortic valve becomes thicker and calcified, preventing it from opening fully and reducing blood flow from the heart to the body's other organs. Heart failure and sudden heart fatalities may result from this. Patients experiencing symptoms and evidence of aortic stenosis are advised to undergo the implant. Patient's quality of life is enhanced with TAVR even if they would otherwise have few remaining therapy alternatives.
Over 1.8 million people in the European Union (EU) and 3.9 million people in Europe lose their lives to cardiovascular disease every year. Furthermore, 37% of all EU fatalities are attributable to CVD. The mortality rates from ischemic heart disease (IHD) and stroke are greater in Central and Eastern Europe compared to Northern, Southern, and Western Europe. Estimates place the number of people with CVD in Europe at 85 million, with about 49 million in the EU. This provides the participants in the transcatheter aortic valve replacement market in the Europe region with excellent growth potential.
The Germany market dominated the Europe Transcatheter Aortic Valve Replacement Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $519.1 million by 2028. The UK market is anticipated to grow at a CAGR of 5.9% during (2022-2028). Additionally, The France market would exhibit a CAGR of 7.6% during (2022-2028).
Based on Material, the market is segmented into Nitinol, Stainless Steel, Cobalt-Chromium and Others. Based on Implantation Procedure, the market is segmented into Transfemoral, Transapical and Transaortic. Based on Mechanism, the market is segmented into Balloon-expanding Valve and Self-expanding Valve. Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Edwards Lifesciences Corporation, MicroPort Scientific Corporation, LivaNova PLC, TTK Healthcare Limited, Meril Life Science Private Limited, JenaValve Technology, Inc., and Bracco S.p.A.
Scope of the Study
By Material
- Nitinol
- Stainless Steel
- Cobalt-Chromium
- Others
By Implantation Procedure
- Transfemoral
- Transapical
- Transaortic
By Mechanism
- Balloon-expanding Valve
- Self-expanding Valve
By End-use
- Hospitals
- Ambulatory Surgical Centers
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Medtronic PLC
- Boston Scientific Corporation
- Edwards Lifesciences Corporation
- MicroPort Scientific Corporation
- LivaNova PLC
- TTK Healthcare Limited
- Meril Life Science Private Limited
- JenaValve Technology, Inc.
- Bracco S.p.A
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Transcatheter Aortic Valve Replacement Market, by Material
1.4.2 Europe Transcatheter Aortic Valve Replacement Market, by Implantation Procedure
1.4.3 Europe Transcatheter Aortic Valve Replacement Market, by Mechanism
1.4.4 Europe Transcatheter Aortic Valve Replacement Market, by End-use
1.4.5 Europe Transcatheter Aortic Valve Replacement Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Transcatheter Aortic Valve Replacement Market
Chapter 4. Europe Transcatheter Aortic Valve Replacement Market by Material
4.1 Europe Nitinol Market by Country
4.2 Europe Stainless Steel Market by Country
4.3 Europe Cobalt-Chromium Market by Country
4.4 Europe Others Market by Country
Chapter 5. Europe Transcatheter Aortic Valve Replacement Market by Implantation Procedure
5.1 Europe Transfemoral Market by Country
5.2 Europe Transapical Market by Country
5.3 Europe Transaortic Market by Country
Chapter 6. Europe Transcatheter Aortic Valve Replacement Market by Mechanism
6.1 Europe Balloon-expanding Valve Market by Country
6.2 Europe Self-expanding Valve Market by Country
Chapter 7. Europe Transcatheter Aortic Valve Replacement Market by End-use
7.1 Europe Hospitals Market by Country
7.2 Europe Ambulatory Surgical Centers Market by Country
7.3 Europe Others Market by Country
Chapter 8. Europe Transcatheter Aortic Valve Replacement Market by Country
8.1 Germany Transcatheter Aortic Valve Replacement Market
8.1.1 Germany Transcatheter Aortic Valve Replacement Market by Material
8.1.2 Germany Transcatheter Aortic Valve Replacement Market by Implantation Procedure
8.1.3 Germany Transcatheter Aortic Valve Replacement Market by Mechanism
8.1.4 Germany Transcatheter Aortic Valve Replacement Market by End-use
8.2 UK Transcatheter Aortic Valve Replacement Market
8.2.1 UK Transcatheter Aortic Valve Replacement Market by Material
8.2.2 UK Transcatheter Aortic Valve Replacement Market by Implantation Procedure
8.2.3 UK Transcatheter Aortic Valve Replacement Market by Mechanism
8.2.4 UK Transcatheter Aortic Valve Replacement Market by End-use
8.3 France Transcatheter Aortic Valve Replacement Market
8.3.1 France Transcatheter Aortic Valve Replacement Market by Material
8.3.2 France Transcatheter Aortic Valve Replacement Market by Implantation Procedure
8.3.3 France Transcatheter Aortic Valve Replacement Market by Mechanism
8.3.4 France Transcatheter Aortic Valve Replacement Market by End-use
8.4 Russia Transcatheter Aortic Valve Replacement Market
8.4.1 Russia Transcatheter Aortic Valve Replacement Market by Material
8.4.2 Russia Transcatheter Aortic Valve Replacement Market by Implantation Procedure
8.4.3 Russia Transcatheter Aortic Valve Replacement Market by Mechanism
8.4.4 Russia Transcatheter Aortic Valve Replacement Market by End-use
8.5 Spain Transcatheter Aortic Valve Replacement Market
8.5.1 Spain Transcatheter Aortic Valve Replacement Market by Material
8.5.2 Spain Transcatheter Aortic Valve Replacement Market by Implantation Procedure
8.5.3 Spain Transcatheter Aortic Valve Replacement Market by Mechanism
8.5.4 Spain Transcatheter Aortic Valve Replacement Market by End-use
8.6 Italy Transcatheter Aortic Valve Replacement Market
8.6.1 Italy Transcatheter Aortic Valve Replacement Market by Material
8.6.2 Italy Transcatheter Aortic Valve Replacement Market by Implantation Procedure
8.6.3 Italy Transcatheter Aortic Valve Replacement Market by Mechanism
8.6.4 Italy Transcatheter Aortic Valve Replacement Market by End-use
8.7 Rest of Europe Transcatheter Aortic Valve Replacement Market
8.7.1 Rest of Europe Transcatheter Aortic Valve Replacement Market by Material
8.7.2 Rest of Europe Transcatheter Aortic Valve Replacement Market by Implantation Procedure
8.7.3 Rest of Europe Transcatheter Aortic Valve Replacement Market by Mechanism
8.7.4 Rest of Europe Transcatheter Aortic Valve Replacement Market by End-use
Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Product Launches and Product Expansions:
9.1.5.2 Approvals and Trials:
9.1.6 SWOT Analysis
9.2 Medtronic PLC
9.2.1 Company overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Product Launches and Product Expansions:
9.2.5.2 Approvals and Trials:
9.2.6 SWOT Analysis
9.3 Boston Scientific Corporation
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Product Launches and Product Expansions:
9.3.5.2 Acquisition and Mergers:
9.3.5.3 Approvals and Trials:
9.4 Edwards Lifesciences Corporation
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.5 MicroPort Scientific Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.6 LivaNova PLC
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.7 TTK Healthcare Limited
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.8 Meril Life Sciences Private Limited
9.8.1 Company Overview
9.9 JenaValve Technology, Inc.
9.9.1 Company Overview
9.10. Bracco S.p.A.
9.10.1 Company Overview
Companies Mentioned
- Abbott Laboratories
- Medtronic PLC
- Boston Scientific Corporation
- Edwards Lifesciences Corporation
- MicroPort Scientific Corporation
- LivaNova PLC
- TTK Healthcare Limited
- Meril Life Science Private Limited
- JenaValve Technology, Inc.
- Bracco S.p.A
Methodology
LOADING...
